Engineers have developed a tiny sensor used to measure the brain pressure in lab mice that they believe has the potential to create the electronic equivalent of touch for advanced prosthetics as well as other applications in medicine.
Sarasota, FL's RPS Diagnostics, maker of point-of-care diagnostic tests for eye conditions, announced Oct. 13 that it has closed a $28 million debt financing with healthcare-focused investment firm OrbiMed.
Invitae already provides testing for at least 15 genetic panels associated with particular diseases for $1,500 each with results coming on average in three weeks. Now it's raised $120 million Series F financing round to build-out its testing infrastructure and expand its global presence.
The FDA approved VisionCare Ophthalmic Technologies' Implantable Miniature Telescope in patients with bilateral end-stage age-related macular degeneration aged 65 or older, the company announced today.
Sterilization and infection prevention products and services company Steris will acquire its more globally-focused peer Synergy Health in a cash and stock deal worth about $1.9 billion.
C.R. Bard's Lutonix 035 Drug Coated Balloon Catheter became the first drug-coated balloon to receive PMA approval from the FDA on Oct. 10. It is indicated for the reopening of narrowed or blocked arteries in the knee or thigh in patients with peripheral artery disease.
Astute Medical will receive $30 million from funding partner CRG.
As med tech companies search for innovative ways to improve device implantation and patient outcomes, a new coating technology from Harvard University scientists could reduce blood clotting and bacterial infection associated with commonly used medical devices.
The U.S. Food and Drug Agency approved Bracco Diagnostics' Lumason, a contrast agent used for patients whose echocardiogram images are difficult to see with ultrasound imaging.
European Union antitrust regulators will now rule on the proposed $13.4 acquisition of Biomet by Zimmer by March 11, instead of Feb. 16, according to the European Commission's website.
Deerfield Management is looking to back a startup that's cornering about one-quarter of the world's supply of a radioisotope commonly used to create diagnostic imaging agents, molybdenum-99 (moly-99). The firm has backed Shine Medical Technologies, which has a novel technology to produce this material, with up to $125 million in debt and equity to build a manufacturing plant in Wisconsin.
C2 Therapeutics raised $11.6 million from 44 investors to help advance its Coldplay Focal Cryoballoon Ablation System to treat Barrett's esophagus.
Medical device cyber security concerns were aroused when a baddie in the show Homeland hacked into the vice president's pacemaker and initiated a fatal heart attack. Now, a report by the European Cybercrime Centre warns of the real rise of similar "ransomware" attacks, although financial gain, not murder, would be the goal.
Days after Medtronic revealed plans to refinance its $42.9 billion acquisition of Covidien due to new tax rules cracking down on inversions, the company announced a corporate shakeup pending the deal's close.
A robotic prosthetic controlled by implanted neuromuscular interfaces has been demonstrated to be clinically successful in a patient for the first time. The researchers expect to treat more patients with novel technology this year. The results are reported in the latest issue of Science Translational Medicine.
Vinod Khosla has shown almost boundless enthusiasm for wearables and med tech. The latest of his investments in this segment came with the recent disclosure of a $13 million investment led by Khosla Ventures in wearable neuromodulator mood company Thync.
Tela Bio, a Pennsylvania-based surgical reconstruction startup in stealth mode, raised $45.4 million from 29 investors, according to an SEC filing.
In a speech emphasizing the importance of compromise, likely presidential candidate Hillary Clinton said that there may be room for that dirty word in Washington when it comes to repealing the 2.3% medical device tax. That is a key demand of Republicans, not to mention of the device industry.
Boston Scientific won a positive recommendation from an FDA panel for its stroke-fighting Watchman device, even as panel members expressed doubt that the product would work well in patients who are eligible for traditional drug therapy.
Startup CoheroHealth, developer of the AsthmaHero app and spirometer for measuring the volume of air inhaled and exhaled by the lungs, will test its solution on 50 patients at New York City's Mount Sinai Medical Center.